(STRO) – Analyst Ratings
-
Oppenheimer Reiterates Outperform Rating on Sutro Biopharma (STRO)
-
Sutro Biopharma (STRO) PT Lowered to $11 at Piper Sandler
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to STRO Stock Lookup